ENOXA (enoxaparin sodium)
Product Description
Les Laboratoires Medis
-
TN -
2018On CPHI since
Categories
Les Laboratoires Medis
-
TN
-
2018On CPHI since
More Products from Les Laboratoires Medis (2)
-
Product BORTESOMIB NEAPOLIS (bortezomib)
Bortezomib NEAPOLIS for Injection is an antineoplastic agent available for intravenous injection (IV) use only.
Each single dose vial contains 3.5 mg of Bortezomib as a sterile lyophilized powder -
Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)
After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.
Les Laboratoires Medis resources (1)
-
Brochure MediS Presentation : Company Profile
This presentation describes the history and the keys dates of MédiS Group
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance